title: Recent developments in health care law: culture and controversy.
abstract: This article reviews recent developments in health care law, focusing on controversy at the intersection of health care law and culture. The article addresses: emerging issues in federal regulatory oversight of the rapidly developing market in direct-to-consumer genetic testing, including questions about the role of government oversight and professional mediation of consumer choice; continuing controversies surrounding stem cell research and therapies and the implications of these controversies for healthcare institutions; a controversy in India arising at the intersection of abortion law and the rights of the disabled but implicating a broader set of cross-cultural issues; and the education of U.S. health care providers and lawyers in the theory and practice of cultural competency.
authors.affiliation: School of Public Policy, Georgia Institute of Technology, 685 Cherry Street, Atlanta, GA 30332-0345, USA. robertaberry@gatech.edu
authors.forename: Roberta M
authors.initials: RM
authors.lastname: Berry
authors.forename: Lisa
authors.initials: L
authors.lastname: Bliss
authors.forename: Sylvia
authors.initials: S
authors.lastname: Caley
authors.forename: Paul A
authors.initials: PA
authors.lastname: Lombardo
authors.forename: Leslie E
authors.initials: LE
authors.lastname: Wolf
mesh_terms: D000029:Abortion, Legal / Q000331:legislation & jurisprudence; D054521:Cultural Competency; D003469:Culture; D003695:Delivery of Health Care / Q000331:legislation & jurisprudence*; D034462:Dissent and Disputes; D005260:Female; D005820:Genetic Testing / Q000331:legislation & jurisprudence; D033161:Government Regulation; D006801:Humans; D007194:India; D008297:Male; D028701:Patient Rights / Q000331:legislation & jurisprudence; D011247:Pregnancy; D057905:Stem Cell Research / Q000331:legislation & jurisprudence; D014481:United States